Clinical trial
An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic…
NCT00765999 · Forest Laboratories, Industry · Completed
Key facts
| NCT number | NCT00765999 |
|---|---|
| Title | An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation |
| Official title | An Open-Label, Long-Term Safety Study of Oral Linaclotide Administered to Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation |
| Lead sponsor | Forest Laboratories, Industry |
| Collaborators | Ironwood Pharmaceuticals, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Constipation, Irritable Bowel Syndrome With Constipation |
| Intervention type | Drug |
| Interventions | Linaclotide |
| Enrollment | 1,559 |
| Start date | Oct 31, 2008 |
| Primary completion | Jan 31, 2012 |
| Completion | Jan 31, 2012 |
| First posted | Oct 3, 2008 |
| Last update posted | Feb 15, 2019 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: